Global Emergency Contraceptive Pills Market was valued at USD 1.00 billion in 2021 and is expected to reach USD 1.14 billion by the year 2028, at a CAGR of 1.8%.
Emergency contraception may be used to prevent pregnancy after unprotected sex. Emergency contraceptive pills (ECPs), also known as contraceptives, are pills that must be taken within 120 hours (5 days) of unprotected sex. In the late 1990s, the prescription Preven Emergency Contraception Kit was created. It was based on the Yuzpe method and included four combination pills, instructions, and a urine bioassay. Some emergency contraception is most effective when used within 72 hours (3 days) of intercourse. The emergency pill functions by delaying ovulation (the release of an egg during the monthly cycle). If fertilization and implantation have already occurred, ECPs will not terminate the pregnancy.
Market Dynamics:
Driver:
The 99% pregnancy prevention guarantee is provided by contraceptive pills. The market for contraceptive drugs and devices is continuing to grow despite the sexual diseases that are rapidly growing. Emergency contraception pills prevent unintended pregnancy by preventing or delaying ovulation and do not induce abortion. This can propel the market of Emergency contraception pills.
Opportunities:
There will be expansion opportunities as a result of the quick uptake of generic contraceptives. Generic contraceptive pills are inexpensive and simple to use. The demand for generic contraceptive pills is rising as the number of abortions rises. Demand will increase as this market continues to develop. One of the major factors anticipated to hasten the growth of the global market for emergency contraceptive pills over the next few years is the increasing awareness of the public. In the coming years, the expansion of the market will likely be supported by the improvement of the distribution network and the easy accessibility of those pills.
Download Free Sample Report:
https://introspectivemarketresearch.com/request/16296
Top Key Players Covered In Emergency Contraceptive Pills Market
Bayer AG (Germany),Teva Pharmaceutical Industries Ltd. (Israel),HRL Laboratories, LLC (USA),Cipla Limited (India),Gedeon Richter Plc. (Hungary),Actavis Group PTC (Iceland),Laboratorios Andrómaco S.A. (Chile),Zhejiang Medicine Group Co., Ltd. (China),Laboratorio SIDI S.A. (Argentina),Hsieh's Holdings Limited (Hong Kong),Aspen Pharmacare Holdings Ltd. (South Africa),Wallace Pharmaceuticals Pty Ltd. (Australia),Wincon Medical Group Co., Ltd. (China),Shandong Lukang Pharmaceutical Group Co., Ltd. (China),Zhengzhou Pharmaceutical Factory Co., Ltd. (China),Chongqing Tianxin Pharmaceutical Co., Ltd. (China),Wuhan Huafei Pharmaceuticals Co., Ltd. (China),Xi'an Zhongmei Pharmaceutical Co., Ltd. (China),Jiangxi Kanbon Pharmaceutical Co., Ltd. (China),Chongqing Jialin Pharmaceutical Co., Ltd. (China).
Segmentation Analysis Of Emergency Contraceptive Pills Market
By Product Type
- Progesterone PillsEstrogen Pills
- Combination Pills
- Others
By Distribution Channel
- Online
- Offline
Inquiry before purchasing:
https://introspectivemarketresearch.com/inquiry/16296
By Region
- North America (U.S., Canada, Mexico)
- Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
- Western Europe (Germany, U.K., France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
- Asia-Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
- Middle East & Africa (Turkey, Saudi Arabia, Bahrain, Kuwait, Qatar, UAE, Israel, South Africa)
- South America (Brazil, Argentina, Rest of SA)
Key Industry Development In The Emergency Contraceptive Pills Market
- In March 2022, FDA urged to allow emergency contraceptive pills. An advocacy group for family planning has urged the Food and Drug Administration (FDA) to reconsider lifting the 20-year-old ban on emergency contraceptive (EC) pills as the country resumes face-to-face operations in the face of declining Covid-19 cases.
- In March 2022, A contraceptive or Morning After pill. A male pill found to be 99 percent effective in mice is predicted to enter human trials by the top of this year. The findings are going to be presented at the American Chemical Society's spring meeting, and mark a key step towards expanding contraception options also as responsibilities for men.
Purchase this report:
https://introspectivemarketresearch.com/checkout/?user=1&_sid=16296
About us:
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.
Contact us:
Introspective Market Research
3001 S King Drive,
Chicago, Illinois
60616 USA
Ph no: +1-773-382-1049
Email : sales@introspectivemarketresearch.com